by Staff Writer

More of this topic

Posted inHealthcare, Latest News, Saudi Arabia, World

Saudi’s KACST and Pfizer to develop new vaccines, gene therapies

Pfizer’s Saudi arm will team up with KACST on the new research and development project

by Staff Writer
Pfizer saudi KACST
Image: Bloomberg

Saudi Arabia’s King Abdulaziz City for Science and Technology (KACST) signed a memorandum of understanding with global pharma major Pfizer to develop vaccines and genetic treatments to combat genetic diseases.

Pfizer’s Saudi arm will team up with KACST on the new research and development project.

The agreement envisages research cooperation in genetic diseases, on aging, infections, immune diseases, cancers, and chronic diseases.

Saudi medical research

It also covers exchanging scientific knowledge, besides Pfizer factories hosting KACST researchers.

The MoU signing event was attended by KACST President Dr. Mounir bin Mahmoud Al-Desouki, and the President of Pfizer Emerging Markets, Nick Lagunowich.
The cooperation between the two also aims to offer advisory support for the Kingdom’s genome programme in its second phase.

It comes as the World Health Organisation has assembled a team of more than 300 scientists to investigate future pandemics and the next global health threat.

The so-called Disease X is an as-yet unknown pathogen that could threaten health around the world on a far greater scale than the Covid-19 pandemic.

Follow us on

For all the latest business news from the UAE and Gulf countries, follow us on Twitter and LinkedIn, like us on Facebook and subscribe to our YouTube page, which is updated daily.